From Our Partners
Thursday, June 23, 2022
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Defense + Military

Development of Assays for Diagnostics, Biothreat Agents

by Global Biodefense Staff
November 21, 2014
Brevetoxin Antibody Research

The U.S. Army Medical Research and Materiel Command (USAMRMC) is looking to develop multiple immunochromatographic tests (ICTs) for the detection of infectious diseases and biological warfare agents (BWA).

USAMRMC has issued a pre-solicitation notice for a small business indefinite delivery indefinite quantity (ID/IQ) contract vehicle for potential activities including development of:

  • Rapid Human Diagnostic Devices (RHDDs) for military-relevant IDs, including: dengue fever and dengue hemorrhagic fever, bacterial gastroenteritis, viral gastroenteritis
  • Biological Warfare Agent (BWA) and related disease rapid diagnostics, such as brucellosis and western/eastern equine encephalitis viruses
  • Arthropod Vector Rapid Detection Devices (AVRDDs) for military-relevant vector-borne diseases including but not limited to dengue virus, Leishmania species, and Plasmodium species

The contractor is required to have manufacturing facilities in compliance with Current Good Manufacturing Practice (cGMP) and will be the sponsor for the 510(k) of each ICT assay for the FDA.

The period of performance (POP) for the ID/IQ contract will be five years in duration, with one 12 month base period, accompanied by 4 twelve month option periods. Each Task Order issued under the ID/IQ for this requirement will have the potential to have a 4 year POP, depending on the advancement/development of the assays required.

Further details are available under Solicitation Number: W81XWH-15-R-0014.

From Our Partners
Tags: BrucellaDengueEquine EncephalitisLeishmaniasisMalariaRequest for Proposals

Related Posts

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control
Medical Countermeasures

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

June 21, 2022
Biodefense Industry News
Industry News

Tonix Pharmaceuticals Opens Advanced Development Center for Vaccine Programs

June 20, 2022
Monkeypox Cases Prompt Additional Contracts for Bavarian Nordic Vaccine
Medical Countermeasures

Monkeypox Cases Prompt Additional Contracts for Bavarian Nordic Vaccine

May 30, 2022
Novavax Missed Its Global Moonshot but Is Angling to Win Over mRNA Defectors
Industry News

Novavax Missed Its Global Moonshot but Is Angling to Win Over mRNA Defectors

May 26, 2022
Load More

Latest News

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

June 22, 2022
UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

June 21, 2022
Influenza Research

New Way to Identify Influenza A Virus Lights Up When Specific Virus Targets are Present

June 20, 2022
Biodefense Industry News

Tonix Pharmaceuticals Opens Advanced Development Center for Vaccine Programs

June 20, 2022

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC